NCT04179968View on ClinicalTrials.gov

The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 27, 2020

Primary Completion Date

September 9, 2021

Study Completion Date

July 15, 2022

Conditions
Prostate CancerProstate Cancer Metastatic
Interventions
DRUG

68Ga PSMA-11 injection

Injection of 68Ga PSMA-11

PROCEDURE

Positron Emission Tomography/Computed Tomography

PET/CT scan after 68Ga PSMA-11 injection

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Dana Mathews

OTHER

NCT04179968 - The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter